These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4118428)

  • 41. Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia.
    Li LH; Neil GL; Moxley TE; Olin EJ
    Cancer Chemother Rep; 1974; 58(3):345-52. PubMed ID: 4858297
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug stimulation of putrescine and spermidine syntheses. Relationships to enhancement of ribonucleic acid synthesis.
    Russell DH
    Biochem Pharmacol; 1971 Dec; 20(12):3481-91. PubMed ID: 5132894
    [No Abstract]   [Full Text] [Related]  

  • 43. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
    Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
    [No Abstract]   [Full Text] [Related]  

  • 44. Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816).
    Lloyd HH; Dulmadge EA; Wilkoff LJ
    Cancer Chemother Rep; 1972 Oct; 56(5):585-91. PubMed ID: 4119906
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anti-tumor effect of glutacyt 2 in leukemia L1210 at different sites].
    Astardzhieva Z; Stoichkov I
    Eksp Med Morfol; 1986; 25(1):28-33. PubMed ID: 3743504
    [No Abstract]   [Full Text] [Related]  

  • 46. Polyamine synthesis during initial phases of stress-induced cardiac hypertrophy.
    Russell DH; Shiverick KT; Hamrell BB; Alpert NR
    Am J Physiol; 1971 Nov; 221(5):1287-91. PubMed ID: 4256528
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of tetrahydrohomofolate on DNA biosynthesis in leukemic mice.
    Mishra LC; Mead JA
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):709-11. PubMed ID: 5118487
    [No Abstract]   [Full Text] [Related]  

  • 48. [Possibilities for the clinical use of 5-azacytidine].
    Veselý J; Cihák A
    Vopr Onkol; 1977; 23(10):65-73. PubMed ID: 74127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An enzymatic-isotopic microassay for putrescine.
    Harik SI; Pasternak GW; Snyder SH
    Biochim Biophys Acta; 1973 May; 304(3):753-64. PubMed ID: 4580200
    [No Abstract]   [Full Text] [Related]  

  • 50. Ornithine decarboxylase and polyamines in silkmoth pupal tissues: effects of ecdysone and injury.
    Wyatt GR; Rothaus K; Lawler D; Herbst EJ
    Biochim Biophys Acta; 1973 Apr; 304(2):482-94. PubMed ID: 4122947
    [No Abstract]   [Full Text] [Related]  

  • 51. Polyamines in bacteriophage phi W-14 and in phi W-14-infected Pseudomonas acidovorans.
    Quail A; Karrer E; Warren RA
    J Gen Virol; 1976 Oct; 33(1):135-8. PubMed ID: 978181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific inhibition of the enzymic decarboxylation of S-adenosylmethionine by methylglyoxal bis(guanylhydrazone) and related substances.
    Corti A; Dave C; Williams-Ashman HG; Mihich E; Schenone A
    Biochem J; 1974 May; 139(2):351-7. PubMed ID: 4447616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia.
    Driscoll JS; Johns DG; Plowman J
    Invest New Drugs; 1985; 3(4):331-4. PubMed ID: 2417984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice.
    Neil GL; Moxley TE; Kuentzel SL; Manak RC; Hanka LJ
    Cancer Chemother Rep; 1975; 59(3):459-65. PubMed ID: 54211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine.
    Baker BR; Ashton WT
    J Med Chem; 1973 Mar; 16(3):209-14. PubMed ID: 4733101
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
    Vadlamudi S; Goldin A
    Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846
    [No Abstract]   [Full Text] [Related]  

  • 57. Biochemical pharmacology of 5,6-dihydro-5-azacytidine (DHAC) and DNA hypomethylation in tumor (L1210)-bearing mice.
    Powell WC; Avramis VI
    Cancer Chemother Pharmacol; 1988; 21(2):117-21. PubMed ID: 2450689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of anti-tumor agents on tRNA methylase activity of leukemia L1210.
    Waalkes TP; Adamson RH; Riddick D; Gallo RC
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):345-52. PubMed ID: 5012444
    [No Abstract]   [Full Text] [Related]  

  • 59. In vivo effects of methotrexate. Inhibition of DNA synthesis and cell death in sensitive and resistant L1210 ascites populations.
    Hofer KG
    Chemotherapy; 1972; 17(1):59-70. PubMed ID: 5009468
    [No Abstract]   [Full Text] [Related]  

  • 60. Complete inhibition of mouse lymphoid leukemia L-1210 by carbazilquinone.
    Arakawa M
    Gan; 1972 Aug; 63(4):487-9. PubMed ID: 5081624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.